Featured Post

Stryker accuses J&J of raiding sales team

Stryker Corp. accuses Johnson & Johnson’s DePuy Orthopaedics subsidiary of conducting a raid on 1 of its sales teams in California. Stryker (NYSE:SYK) accused the DePuy Orthopaedics subsidiary of Johnson & Johnson (NYSE:JNJ) of gutting its presence in the northern California orthopedic...

Read More

So… tell me about yourself

Posted by Joe Baker | Posted in Career Advice, Career Development, General, Interviewing Tips | Posted on 24-10-2014



Most often, the first question you’re going to get in an interview is, “Tell me about yourself.” This doesn’t mean you should recite your entire life story or regurgitate your resume. Instead, it’s your opportunity to sell the hiring manager on why you’re the right one for the job.

A simple formula that works is the Present-Past-Future. You start with the present—where you are right now. Then, segue into the past—a little bit about the experiences you’ve had and the skills you gained at the previous position. Finally, finish with the future—why you are really excited for this particular opportunity.

Here’s an example:

Hiring Manager: Hi Kelly. Why don’t you start by telling me a little bit about yourself?

Kelly: Sure. I’m currently an account manager at Blue Bird Medical, where I am ranked number two out of 14 reps on our regional diagnostics sales team. Before that, I worked at JNR Linen Service as an outside sales rep for two and a half years—until I was recruited to work at Blue Bird. While I really enjoy the work that I do, I’d love the chance to dig in much deeper with one specific healthcare company, which is why I’m so excited about this opportunity with Gemini Medical.

Remember throughout your answer to focus on the experiences and skills that are going to be most relevant for the hiring manager when they’re thinking about this particular position and this company. Remember to relax a little and share some appropriate anecdotes. The hiring manager already has your resume. The purpose of an interview is to learn more about you and see if your chemistry and personality are a fit for their team.

For more interview tips, check out Medical Sales Coaching.

Ralph Steeber, CEO  – Career Coach and Recruiting Entrepreneur
Joe Baker, Director  –  Career Coach and Social Media Expert

FDA approves CoverEdge by Boston Scientific to address chronic pain

Posted by Joe Baker | Posted in BioTech News, General, Industry News, Medical Device News, Press Release | Posted on 23-10-2014



Bost Sci flag


Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) and CE Mark approval for the CoverEdge™ 32 and CoverEdge™ X 32 Surgical Leads,  the world’s first 32-contact surgical leads designed to blanket the spinal cord for unprecedented pain coverage.  Designed for use with the Precision Spectra™ Spinal Cord Stimulator (SCS) System. Boston Scientific is introducing the CoverEdge Surgical Leads at the Congress of Neurological Surgeons (CNS) this week in Boston.

Intuitive Surgical third quarter earnings up 10% from 2013

Posted by Joe Baker | Posted in BioTech News, General, Industry News, Medical Device News, Press Release | Posted on 22-10-2014




Intuitive Surgical, Inc. (Nasdaq:ISRG), the industry leader in robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2014.

Q3 Highlights

  • Worldwide da Vinci procedures grew nearly 10% over the third quarter of 2013.
  • The Company placed 111 da Vinci Surgical Systems, compared to 101 in the third quarter of 2013 and 96 in the second quarter of 2014.
  • The Company increased da Vinci Xi System sales from 50 during the second quarter of 2014, the quarter of launch, to 59 in the third quarter of 2014.
  • The Company’s Firefly fluorescence imaging product was cleared by the FDA for use with da Vinci Xi.
  • The Company’s wristed Single-Site needle driver was cleared by the FDA for use on benign hysterectomy, cholecystectomy, and salpingo-oophorectomy procedures.

Q3 Financial Summary

Revenue in the third quarter of 2014 was $550 million, an increase of approximately 10% compared with $499 million in the third quarter of 2013.

Third quarter 2014 GAAP instrument and accessory revenue increased by approximately 14% to $273 million compared with$239 million for the third quarter of 2013. The increase in revenue was driven by approximately 10% higher da Vinci procedure volume and timing of customer orders. Higher procedure volume was driven by growth in U.S. general surgery procedures and worldwide urologic procedures.

Systems revenue increased to $169 million in the third quarter of 2014, compared with $159 million for the third quarter of 2013. Systems revenue decreased to $154 million in the third quarter of 2014, compared with $159 million for the third quarter of 2013. Intuitive Surgical shipped 111 da Vinci Surgical Systems during the three months ending September 30, 2014, compared with 101 in the same period last year.

Intuitive Surgical ended the third quarter of 2014 with $2.3 billion in cash, cash equivalents, and investments, an increase of$219 million during the quarter, primarily driven by cash generated from operations.

Commenting on the announcement, Dr. Gary Guthart, President and CEO of Intuitive Surgical, said, “We are pleased with our third quarter procedure and da Vinci system placement growth, the positive surgeon response to our da Vinci Xi System, and our progress in expanding our international business.”